• 1
    McColl MD, Ramsay JE, Tail RC et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997; 78: 11831188.
  • 2
    Kierkegaard A. Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Acta Obstet Gynecol Scand 1983; 62: 239243.
  • 3
    James K, Lohr J, Deshmukh R, Cranley J. Venous thrombotic complications of pregnancy. Cardiovasc Surg 1996; 4: 777782.
  • 4
    Department of Health. Report on Confidential enquiries into Maternal Deaths in the United Kingdom 1994–1996. London : HMSO, 1998.
  • 5
    Bertina RM, Koeleman BP, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 6467.
  • 6
    Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 36983703.
  • 7
    Arruda VR, Annichino-Bizzacchi JM, Goncalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997; 78: 14301433.
  • 8
    Brown K, Luddington R, Williamson D, Baker P, Baglin T. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3'-untranslated region of the prothrombin gene. Br J Haematol 1997; 98: 907909.
  • 9
    Cumming AM, Keeney S, Salden A, Bhavnani M, Shwe KH, Hay CR. The prothrombin gene G20210A variant: prevalence in a UK. anticoagulant clinic population. Br J Haematol 1997; 98: 353355.
  • 10
    Hillarp A, Zoller B, Svensson PJ, Dahlback B. The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 1997; 78: 990992.
  • 11
    Kapur RK, Mills LA, Spitzer SG, Hultin MB. A prothrombin gene mutation is significantly associated with venous thrombosis. Arterioscler Thromb Vasc Biol 1997; 17: 28752879.
  • 12
    McColl M, Walker I, Greer I. A mutation in the prothrombin gene contributing to venous thrombosis during pregnancy. Br J Obstet Gynaecol 1998; 105: 923925.
  • 13
    Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 1995; 10: 111113.
  • 14
    Kluijtmans LA, van den Heuvel LP, Boers GH et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 3541.
  • 15
    Girelli D, Friso S, Trabetti E et al. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood 1998; 91: 41584163.
  • 16
    den Heijer M, Koster T, Blom HJ et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759762.
  • 17
    McColl MD, Chalmers EA, Thomas A et al. Factor V Leiden, prothrombin 20210 G-A and the MTHFRC677 T mutations in childhood stroke. Thromb Haemost 1999; 81: 690694.
  • 18
    Tait RC, Walker ID, Perry DJ et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87: 106112.
  • 19
    The Royal College of Obstetricians and Gynaecologists. Report of the RCOG Working Party on Prophylaxis Against Thromboembolism in Gynaecology and Obstetrics. London : RCOG, 1995.
  • 20
    Conard J, Horellou MH, Van Dreden P, Lecompte T, Samama M. Thrombosis and pregnancy in congenital deficiencies in ATIII, protein C or protein S: study of 78 women. Thromb Haemost 1990; 63: 319320.
  • 21
    Friederich P, Sanson B, Simioni P et al. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Int Med 1996; 125: 955960.
  • 22
    Pabinger I, Schneider B. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft für Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors. Arterioscler Thromb Vasc Biol 1996; 16: 742748.
  • 23
    Hough R, Makris M, Preston F. Pregnancy in women with thrombophilia: incidence of thrombosis and pregnancy outcome. Br J Haematol 1996; 93 (Suppl): 1.
  • 24
    Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 11331134.
  • 25
    Franco RF, Santos SE, Elion J, Tavella MH, Zago MA. Prevalence of the G20210 a polymorphism in the 3'-untranslated region of the prothrombin gene in different human populations. Acta Haematol 1998; 100: 912.
  • 26
    Hellgren M, Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol 1995; 173: 210213.
  • 27
    Bokarewa MI, Bremme K, Blomback M. Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy. Br J Haematol 1996; 92: 473478.
  • 28
    Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997; 90: 17471750.
  • 29
    De Stefano V, Chiusolo P, Paciaroni K et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 1998; 91: 35623565.
  • 30
    Martinelli I, Cattaneo M, Panzeri D, Mannucci P. Low prevalence of factor V: Q506 in 41 patients with isolated pulmonary embolism. Thromb Haemost 1997; 77: 440443.
  • 31
    Baglin T, Brown K, Williamson D, Baker P, Luddington R. Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V Leiden mutation in a United Kingdom population. Thromb Haemost 1997; 77: 1219.
  • 32
    Desmarais S, Moerloose P, Reber G, Minazio P, Perrier A, Bounameaux H. Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet 1996; 347: 13741375.
  • 33
    Turkstra F, Karemaker R, Kuijer P, Prins M, Buller H. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different Thromb Haemost 1999; 81: 345348.
  • 34
    Kluijtmans LA, den Heijer M, Reitsma PH, Heil SG, Blom HJ, Rosendaal FR. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thromb Haemost 1998; 79: 254258.
  • 35
    Andersson A, Hultberg B, Brattstrom L, Isaksson A. Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem 1992; 30: 377379.
  • 36
    McColl M, Walker I, Greer I. The role of inherited thrombophilia in venous thromboembolism associated with pregnancy. Br J Obstet Gynaecol 1999; 106: 756766.